Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Leishmaniasis immunopathology—impact on design and use of vaccines, diagnostics and drugs
Paul M. Kaye, Israel Cruz, Albert Picado, et al.
Seminars in Immunopathology (2020) Vol. 42, Iss. 3, pp. 247-264
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Status and Future Scope of Soft Nanoparticles-Based Hydrogel in Wound Healing
Marcel Henrique Marcondes Sari, Alexandre de Fátima Cobre, Roberto Pontarolo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 874-874
Open Access | Times Cited: 30
Vaccine value profile for leishmaniasis
Paul M. Kaye, Greg Matlashewski, Sakshi Mohan, et al.
Vaccine (2023) Vol. 41, pp. S153-S175
Open Access | Times Cited: 23
Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development
Greta Volpedo, Thalia Pacheco‐Fernández, Parna Bhattacharya, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 44
Loop-Mediated Isothermal Amplification as Point-of-Care Diagnosis for Neglected Parasitic Infections
Catalina Avendaño, Manuel A. Patarroyo
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 7981-7981
Open Access | Times Cited: 44
Revival of Leishmanization and Leishmanin
Thalia Pacheco‐Fernández, Greta Volpedo, Sreenivas Gannavaram, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 39
Diagnosis of visceral and cutaneous leishmaniasis using loop-mediated isothermal amplification (LAMP) protocols: a systematic review and meta-analysis
Astrid C. Erber, Peter Julian Sandler, Daniel Moreira de Avelar, et al.
Parasites & Vectors (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 25
Immunoinformatics Approach to Design a Multi-Epitope Nanovaccine against Leishmania Parasite: Elicitation of Cellular Immune Responses
Maritsa Margaroni, Maria Agallou, Evgenia Tsanaktsidou, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 304-304
Open Access | Times Cited: 14
Immunotherapy and immunochemotherapy in combating visceral leishmaniasis
Ganesh Yadagiri, Aakriti Singh, Kanika Arora, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 14
Overcoming roadblocks in the development of vaccines for leishmaniasis
Paul M. Kaye, Sakshi Mohan, Carsten Mantel, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 11, pp. 1419-1430
Open Access | Times Cited: 32
Photodynamic therapy for leishmaniasis: Recent advances and future trends
Mohammad Varzandeh, Reza Mohammadinejad, Keyvan Esmaeilzadeh‐Salestani, et al.
Photodiagnosis and Photodynamic Therapy (2021) Vol. 36, pp. 102609-102609
Closed Access | Times Cited: 25
Identification of Metabolically Quiescent Leishmania mexicana Parasites in Peripheral and Cured Dermal Granulomas Using Stable Isotope Tracing Imaging Mass Spectrometry
Joachim Kloehn, Berin A. Boughton, Eleanor Saunders, et al.
mBio (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 24
Nanomedicine in leishmaniasis: A promising tool for diagnosis, treatment and prevention of disease - An update overview
João Paulo Assolini, Amanda Cristina Machado Carloto, Bruna Taciane da Silva Bortoleti, et al.
European Journal of Pharmacology (2022) Vol. 923, pp. 174934-174934
Closed Access | Times Cited: 19
Ozone Therapy on Wound Healing by American Cutaneous Leishmaniasis: Preliminary Study
Franciane Aguiar Santana Matos, Henrique Cunha Carvalho, Adjaci Uchôa Fernandes, et al.
Ozone Science and Engineering (2025), pp. 1-5
Closed Access
Molecular interaction assays in silico of crotapotin from Crotalus durissus terrificus against the molecular target trypanothione reductase from Leishmania braziliensis
Jamile Mariano Macedo, M. F. V. Souza, Anderson Maciel de Lima, et al.
˜The œJournal of venomous animals and toxins including tropical diseases (2025) Vol. 31
Open Access
Recent Advances in Research on Inhibitory Effects of Seaweed Extracts Against Parasites
Wenbing Cheng, Xiaosen Yang, Dengfeng Yang, et al.
Marine Drugs (2025) Vol. 23, Iss. 4, pp. 171-171
Open Access
Memory T Cell Subsets Expressing Tissue Homing Receptors and Chemokine Levels in Human Tegumentary Leishmaniasis
Julia Pimentel, María Fernanda García Bustos, Paula G. Ragone, et al.
Cells (2025) Vol. 14, Iss. 8, pp. 604-604
Open Access
Characterization of a novel Leishmania antigen containing a repetitive domain and its potential use as a prophylactic and therapeutic vaccine
Bianca de Oliveira, Wanessa Goes, Frederico Crepaldi Nascimento, et al.
mSphere (2025)
Open Access
Global, regional, and national burden of Visceral leishmaniasis, 1990–2021: findings from the global burden of disease study 2021
Shun-Xian Zhang, Guo-Bing Yang, Jian-Yong Sun, et al.
Parasites & Vectors (2025) Vol. 18, Iss. 1
Open Access
Transdifferentiation of neutrophils facilitates the establishment of infection by Leishmania donovani parasites
Madhurima Roy, Aniruddha Bagchi, Chaitali Karmakar, et al.
Infection and Immunity (2025)
Open Access
Immunotherapy for visceral leishmaniasis: A trapeze of balancing counteractive forces
Priyanka H. Mazire, Bhaskar Saha, Amit Roy
International Immunopharmacology (2022) Vol. 110, pp. 108969-108969
Closed Access | Times Cited: 13
From classical approaches to new developments in genetic engineering of live attenuated vaccine against cutaneous leishmaniasis: potential and immunization
Zahra Rooholamini, Hassan Dianat‐Moghadam, Mahsa Esmaeilifallah, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 2
Status of IL‐4 and IL‐10 driven markers in experimental models of Visceral Leishmaniasis
Srija Moulik, Joyshree Karmakar, Sumit Joshi, et al.
Parasite Immunology (2020) Vol. 43, Iss. 1
Closed Access | Times Cited: 18
Intravacuolar Pathogens Hijack Host Extracellular Vesicle Biogenesis to Secrete Virulence Factors
Anna Gioseffi, Mariola J. Edelmann, Peter E. Kima
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 16
Pharmacokinetics and pharmacodynamics in the treatment of cutaneous leishmaniasis – challenges and opportunities
Katrien Van Bocxlaer, Simon L. Croft
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 4, pp. 472-482
Open Access | Times Cited: 15
Toll-Like Receptor- and Protein Kinase R-Induced Type I Interferon Sustains Infection of Leishmania donovani in Macrophages
Bruna Torres Dias, Amy Goundry, Áislan de Carvalho Vivarini, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top